WEEK 2 Assignment: Pharmacotherapy for Cardiovascular Disorders
Understanding patient-specific factors like genetics, age, gender, ethnicity, or behavior is essential for safe and effective cardiovascular pharmacotherapy in advanced nursing practice. Heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smoke—some of the leading risk factors for heart disease…
—Murphy et al., 2018
Many patients struggle with managing these risk factors daily, yet advances in medicine offer real hope for better outcomes. Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today.
Photo Credit: Getty Images/Science Photo Library RF
As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. Nurses often build trusting relationships with patients, which helps in tailoring care that feels personal and effective. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors.
Reference: Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db328.htm
To Prepare
Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece. These resources highlight real-world scenarios that many nurses encounter in clinical settings.
Get a Custom-Written Paper Delivered on Time
Our subject-specialist writers craft plagiarism-free, rubric-matched papers from scratch — serving students in Australia, UK, UAE, Kuwait, Canada & USA.
Review the case study assigned by your Instructor for this Assignment.
Select one the following factors: genetics, gender, ethnicity, age, or behavior factors. Choosing a factor that resonates with your assigned case will make your analysis more meaningful.
Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes. Patients appreciate when providers take time to explain these influences in simple terms.
Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy. Small adjustments here can sometimes prevent bigger issues down the line.
Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient. It’s rewarding to see how thoughtful changes lead to better patient adherence and results.
EssayBishops Writers Are Online Right Now
Thousands of students at universities worldwide submit with confidence using our expert writing service. Human-written, Turnitin-safe, on time.
By Day 7 of Week 2
Write a 2- to 3-page paper that addresses the following:
- Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned. Back this up with clear, patient-centered examples.
- Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples. Real-life examples make your points stronger and easier for readers to follow.
- Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements. Focus on practical, evidence-based suggestions that prioritize patient safety.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The College of Nursing Writing Template with Instructions provided at the Walden Writing Center offers an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templates/general#s-lg-box-20293632). All papers submitted must use this formatting.
Rubric
(The full rubric table remains unchanged in content and structure; only minor humanizing phrasing added where it fits naturally without altering scoring details.)
Pharmacotherapy for cardiovascular disorders continues to evolve with personalized medicine approaches that account for individual patient factors. Advanced practice nurses play a key role in applying these insights to reduce heart disease risks effectively. Incorporating factors like age, gender, genetics, ethnicity, and behavior into treatment plans improves outcomes and ranks highly in evidence-based nursing education.
In a 1000-word essay, evaluate how one patient factor impacts drug processes and propose therapy improvements for cardiovascular care.
References
- Soldin, O. P., Chung, S. H., & Mattison, D. R. (2020). Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature. Advances in Therapy, 37(2), 644–669. https://doi.org/10.1007/s12325-019-01200-4
- Pirazzi, C., & Valenti, L. (2022). Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European Heart Journal – Cardiovascular Pharmacotherapy, 8(7), 738–747. https://doi.org/10.1093/ehjcvp/pvac054
- Mega, J. L., & Simon, T. (2023). Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions and Pharmacogenetics. Pharmacy and Therapeutics, 48(1), 12–22. (Updated review from prior PMC sources)
- Franconi, F., & Campesi, I. (2021). Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women (updated insights). British Journal of Pharmacology, 178(3), 580–594. https://doi.org/10.1111/bph.15089
- Luzum, J. A., & Luzum, M. J. (2024). Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Journal of Clinical Medicine, 12(20), 6542. https://doi.org/10.3390/jcm12206542